In the present study, despite an increase in TGFβR2 levels in hPAH patients and two animal models of PAH, we did not observe an increase in TGFβR1 levels in all analyses (immunofluorescence, mRNA and protein). Here, TGFBR2 is linked to pulmonary arterial hypertension.